Abstract
Objectives
We conducted a cost-effectiveness analysis and model-based cost–utility and cost–benefit analysis of increased dosage (3 vs. 1 consecutive contests) and enhanced content (supplemental smoking-cessation counseling) of the Quit-and-Win contest using data from a randomized control trial enrolling college students in the US.
Methods
For the cost–utility and cost–benefit analyses, we used a microsimulation model of the life course of current and former smokers to translate the distribution of the duration of continuous abstinence among each treatment arm’s participants observed at the end of the trial (N = 1217) into expected quality-adjusted life-years (QALYs) and costs and an incremental net monetary benefit (INMB). Missing observations in the trial were classified as smoking. For our reference case, we took a societal perspective and used a 3% discount rate for costs and benefits. A probabilistic sensitivity analysis (PSA) was performed to account for model and trial-estimated parameter uncertainty. We also conducted a cost-effectiveness analysis (cost per additional intermediate cessation) using direct costs of the intervention and two trial-based estimates of intermediate cessation: (a) biochemically verified (BV) 6-month continuous abstinence and (b) BV 30-day point prevalence abstinence at 6 months.
Results
Multiple contests resulted in a significantly higher BV 6-month continuous abstinence rate (RD 0.04), at a cost of $1275 per additional quit, and increased the duration of continuous abstinence among quitters. In the long run, multiple contests lead to an average gain of 0.03 QALYs and were cost saving. Incorporating parameter uncertainty into the analyses, the expected INMB was greater than $1000 for any realistic willingness to pay (WTP) for a QALY.
Conclusions
Assuming missing values were smoking, multiple contests appear to dominate a single contest from a societal perspective. Funding agencies seeking to promote population health by funding a Quit-and-Win contest in a university setting should strongly consider offering multiple consecutive contests. Further research is needed to evaluate multiple contests compared to no contest.
Similar content being viewed by others
Notes
Health-related quality of life measures (derived from the EuroQol 5-item and a self-reported General Health Status) were available for trial participants at baseline and 6 months. However, we found no difference across arms and comparing quitters to non-quitters. We, therefore, do not discuss them.
We could not find these values for a US population.
The justification for this is given below.
The sample size for each of the four treatment arms was as follows. Single Contest Arm = 306; Single Contest + Counseling Arm = 296; Multiple Contest Arm = 309; Multiple Contest + Counseling Arm = 306.
References
U.S. Department of Health and Human Services: The Health Consequences of Smoking: 50 Years of Progress. A Report of the Surgeon General. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, Washington, D.C. (2014)
Taylor, D.H., Hasselblad, V., Henley, S.J., Thun, M.J., Sloan, F.A.: Benefits of smoking cessation for longevity. Am. J. Public Health 92(6), 990–996 (2002)
Jha, P., Ramasundarahettige, C., Landsman, V., Rostron, B., Thun, M., Anderson, R.N., McAfee, T., Peto, R.: 21st-century hazards of smoking and benefits of cessation in the United States. N. Engl. J. Med. 368(4), 341–350 (2013). https://doi.org/10.1056/NEJMsa1211128
Center for Disease Control and Prevention: Current cigarette smoking among adults—United States, 2005–2014. Morb. Mortal. Wkly. Rep. MMWR 64(44), 1233–1240 (2015)
Hughes, J.R., Keely, J., Naud, S.: Shape of the relapse curve and long-term abstinence among untreated smokers. Addiction 99(1), 29–38 (2004)
Stead, L.F., Perera, R., Bullen, C., Mant, D., Hartmann-Boyce, J., Cahill, K., Lancaster, T.: Nicotine replacement therapy for smoking cessation. Cochrane Database Syst. Rev. 11, CD000146 (2012). https://doi.org/10.1002/14651858.cd000146.pub4
Hughes, J.R., Cohen, B., Callas, P.W.: Treatment seeking for smoking cessation among young adults. J. Subst. Abuse Treat. 37(2), 211–213 (2009). https://doi.org/10.1016/j.jsat.2008.11.006
Solberg, L.I., Boyle, R.G., McCarty, M., Asche, S.E., Thoele, M.J.: Young adult smokers: are they different? Am. J. Manag. Care 13(11), 626–632 (2007)
Cahill, K., Perera, R.: Quit and win contests for smoking cessation. Cochrane Database Syst Rev 4, CD004986 (2008). https://doi.org/10.1002/14651858.cd004986.pub3
Thomas, J.L., Luo, X., Bengtson, J., Wang, Q., Ghidei, W., Nyman, J., Lust, K., An, L., Wetter, D.W., Epstein, L., Ahluwalia, J.S.: Enhancing Quit & Win contests to improve cessation among college smokers: a randomized clinical trial. Addiction 111(2), 331–339 (2016). https://doi.org/10.1111/add.13144
VanKim, N.A., Laska, M.N., Ehlinger, E., Lust, K., Story, M.: Understanding young adult physical activity, alcohol and tobacco use in community colleges and 4-year post-secondary institutions: a cross-sectional analysis of epidemiological surveillance data. BMC Public Health 10, 208 (2010). https://doi.org/10.1186/1471-2458-10-208
Vidrine, J.I., Reitzel, L.R., Figueroa, P.Y., Velasquez, M.M., Mazas, C.A., Cinciripini, P.M., Wetter, D.W.: Motivation and problem solving (MAPS): motivationally based skills training for treating substance use. Cognit. Behav. Pract. 20(4), 501–516 (2013)
Sanders, G.D., Neumann, P.J., Basu, A., et al.: Recommendations for conduct, methodological practices, and reporting of cost-effectiveness analyses: second panel on cost-effectiveness in health and medicine. JAMA 316(10), 1093–1103 (2016). https://doi.org/10.1001/jama.2016.12195
Gold, M.R., Siegel, J.E., Russell, L.B., Weinstein, M.C. (eds.): Cost-Effectiveness in Health and Medicine. Oxford University Press, Oxford (1996)
R Core Team: R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing, Vienna (2013)
Hughes, J.R., Peters, E.N., Naud, S.: Relapse to smoking after 1 year of abstinence: a meta-analysis. Addict. Behav. 33(12), 1516–1520 (2008). https://doi.org/10.1016/j.addbeh.2008.05.012
Wagner, T.H., Goldstein, M.K.: Behavioral interventions and cost-effectiveness analysis. Prev. Med. 39(6), 1208–1214 (2004). https://doi.org/10.1016/j.ypmed.2004.04.052
Prenger, R., Pieterse, M.E., Braakman-Jansen, L.M.A., van der Palen, J., Christenhusz, L.C.A., Seydel, E.R.: Moving beyond a limited follow-up in cost-effectiveness analyses of behavioral interventions. Eur. J. Health Econ. 14(2), 297–306 (2013). https://doi.org/10.1007/s10198-011-0371-6
Pierce, J.P., Gilpin, E.A.: A minimum 6-month prolonged abstinence should be required for evaluating smoking cessation trials. Nicotine Tob. 5(2), 151–153 (2003)
Hughes, J.R., Keely, J.P., Niaura, R.S., Ossip-Klein, D.J., Richmond, R.L., Swan, G.E.: Measures of abstinence in clinical trials: issues and recommendations. Nicotine Tob. Res. 5(1), 13–25 (2003)
Agresti, A.: Categorical Data Analysis, 2nd edn. Wiley, New York (2002)
Robins, J.: A new theory of causality in observational survival studies—application to the healthy worker effect. Biometrics 1, 331 (1985)
Bureau of Labor Statistics: CPI Inflation Calculator. https://data.bls.gov/cgi-bin/cpicalc.pl. Accessed 08 Jan 2017 (2017)
United States Census Bureau: https://www.census.gov/. Accessed 08 Jan 2017 (2017)
Bureau of Labor Statistics: https://www.bls.gov/. Accessed 08 Jan 2017 (2017)
US Department of Labor: https://www.dol.gov/whd/minwage/chart.htm. Accessed 08 Jan 2017 (2017)
Carpenter, J., Bithell, J.: Bootstrap confidence intervals: when, which, what? A practical guide for medical statisticians. Stat. Med. 19(9), 1141–1164 (2000)
Sonnenberg, F.A., Beck, J.R.: Markov models in medical decision making: a practical guide. Med. Decis. Mak. 13(4), 322–338 (1993)
Center for Disease Control and Prevention: Quitting smoking among adults—United States, 2001–2010. Morbid. Mortal. Wkly. Rep. MMWR 60(44), 1513–1519 (2011)
Jia, H., Lubetkin, E.I.: Trends in quality-adjusted life-years lost contributed by smoking and obesity. Am. J. Prev. Med. 38(2), 138–144 (2010). https://doi.org/10.1016/j.amepre.2009.09.043
Maciosek, M.V., Xu, X., Butani, A.L., Pechacek, T.F.: Smoking-attributable medical expenditures by age, sex, and smoking status estimated using a relative risk approach. Prev. Med. 77, 162–167 (2015). https://doi.org/10.1016/j.ypmed.2015.05.019
Rasmussen, S.R., Prescott, E., Sorensen, T.I., Sogaard, J.: The total lifetime costs of smoking. Eur. J. Public Health 14(1), 95–100 (2004)
Rasmussen, S.R., Prescott, E., Sorensen, T.I., Sogaard, J.: The total lifetime health cost savings of smoking cessation to society. Eur. J. Public Health 15(6), 601–606 (2005). https://doi.org/10.1093/eurpub/cki024
Caro, J.J., Moller, J., Getsios, D.: Discrete event simulation: the preferred technique for health economic evaluations? Value Health 13(8), 1056–1060 (2010). https://doi.org/10.1111/j.1524-4733.2010.00775.x
Cahill, K., Stevens, S., Perera, R., Lancaster, T.: Pharmacological interventions for smoking cessation: an overview and network meta-analysis. Cochrane Database Syst. Rev. 5, CD009329 (2013). https://doi.org/10.1002/14651858.cd009329.pub2
Vogl, M., Wenig, C.M., Leidl, R., Pokhrel, S.: Smoking and health-related quality of life in English general population: implications for economic evaluations. BMC Public Health 12, 203 (2012). https://doi.org/10.1186/1471-2458-12-203
Dougherty, R.L., Edelman, A.S., Hyman, J.M.: Nonnegativity-, monotonicity-, or convexity-preserving cubic and quintic Hermite interpolation. Math. Comput. 52(186), 471–494 (1989)
Shields, M., Garner, R.E., Wilkins, K.: Dynamics of smoking cessation and health-related quality of life among Canadians. Health Rep. 24(2), 3–11 (2013)
Burns, D.M.: Cigarette smoking among the elderly: disease consequences and the benefits of cessation. Am. J. Health Promot. AJHP 14(6), 357–361 (2000)
Lubin, J.H., Caporaso, N.E.: Cigarette smoking and lung cancer: modeling total exposure and intensity. Cancer Epidemiol. Biomark. Prevent. 15(3), 517–523 (2006). https://doi.org/10.1158/1055-9965.epi-05-0863
Tom’s Inflation Calculor: US Bureau of Labor Statistics. http://www.halfhill.com/inflation_js.html. Accessed 30 Aug 2017
Bunn 3rd, W.B., Stave, G.M., Downs, K.E., Alvir, J.M., Dirani, R.: Effect of smoking status on productivity loss. J. Occup. Environ. Med. 48(10), 1099–1108 (2006). https://doi.org/10.1097/01.jom.0000243406.08419.74
Berman, M., Crane, R., Seiber, E., Munur, M.: Estimating the cost of a smoking employee. Tob. Control 23(5), 428–433 (2014). https://doi.org/10.1136/tobaccocontrol-2012-050888
O’Hagan, A., Stevenson, M., Madan, J.: Monte Carlo probabilistic sensitivity analysis for patient level simulation models: efficient estimation of mean and variance using ANOVA. Health Econ. 16(10), 1009–1023 (2007). https://doi.org/10.1002/hec.1199
Fenwick, E., Marshall, D.A., Levy, A.R., Nichol, G.: Using and interpreting cost-effectiveness acceptability curves: an example using data from a trial of management strategies for atrial fibrillation. BMC Health Serv. Res. 6(1), 52 (2006). https://doi.org/10.1186/1472-6963-6-52
Claxton, K.: The irrelevance of inference: a decision-making approach to the stochastic evaluation of health care technologies. J. Health Econ. 18(3), 341–364 (1999)
Fiore, M., Jaen, C.R., Baker, T., Bailey, W., Benowitz, N., Curry, S., Dorfman, S.: Treating Tobacco Use and Dependence: 2008 Update. Clinical Practice Guideline. U.S. Department of Health and Human Services, Public Health Service, Rockville (2008)
Hughes, J.R., Fanshawe, T.R., Stead, L.F.: Is nicotine replacement really ineffective? A reply to Stanley and Massey. J. Clin. Epidemiol. (2016). https://doi.org/10.1016/j.jclinepi.2016.08.013
Simmons, V.N., Heckman, B.W., Fink, A.C., Small, B.J., Brandon, T.H.: Efficacy of an experiential, dissonance-based smoking intervention for college students delivered via the internet. J. Consult. Clin. Psychol. 81(5), 810–820 (2013). https://doi.org/10.1037/a0032952
Müssener, U., Bendtsen, M., Karlsson, N., White, I.R., McCambridge, J., Bendtsen, P.: Effectiveness of short message service text-based smoking cessation intervention among university students: a randomized clinical trial. JAMA Intern. Med. 176(3), 321–328 (2016)
Salize, H.J., Merkel, S., Reinhard, I., Twardella, D., Mann, K., Brenner, H.: Cost-effective primary care-based strategies to improve smoking cessation: more value for money. Arch. Intern. Med. 169(3), 230–235 (2009). https://doi.org/10.1001/archinternmed.2008.556. (discussion 235–236)
Hollis, J.F., McAfee, T.A., Fellows, J.L., Zbikowski, S.M., Stark, M., Riedlinger, K.: The effectiveness and cost effectiveness of telephone counselling and the nicotine patch in a state tobacco quitline. Tob. Control 16(Suppl 1), i53–i59 (2007). https://doi.org/10.1136/tc.2006.019794
Hoogendoorn, M., Welsing, P., Rutten-van Mölken, M.P.M.H.: Cost-effectiveness of varenicline compared with bupropion, NRT, and nortriptyline for smoking cessation in the Netherlands. Curr. Med. Res. Opin. 24(1), 51–61 (2008). https://doi.org/10.1185/030079908X242917
Lancaster, T., Stead, L.F.: Individual behavioural counselling for smoking cessation. Cochrane Database Syst. Rev. 3, CD001292 (2017). https://doi.org/10.1002/14651858.cd001292.pub3
Stead, L.F., Hartmann-Boyce, J., Perera, R., Lancaster, T.: Telephone counselling for smoking cessation. Cochrane Database Syst. Rev. 8, CD002850 (2013). https://doi.org/10.1002/14651858.cd002850.pub3
Harris, K.J., Catley, D., Good, G.E., Cronk, N.J., Harrar, S., Williams, K.B.: Motivational interviewing for smoking cessation in college students: a group randomized controlled trial. Prev. Med. 51(5), 387–393 (2010). https://doi.org/10.1016/j.ypmed.2010.08.018
West, R., Hajek, P., Stead, L., Stapleton, J.: Outcome criteria in smoking cessation trials: proposal for a common standard. Addiction 100(3), 299–303 (2005). https://doi.org/10.1111/j.1360-0443.2004.00995.x
Kristman, V., Manno, M., Cote, P.: Loss to follow-up in cohort studies: how much is too much? Eur. J. Epidemiol. 19(8), 751–760 (2004)
Little, R.J., D’Agostino, R., Cohen, M.L., Dickersin, K., Emerson, S.S., Farrar, J.T., Frangakis, C., Hogan, J.W., Molenberghs, G., Murphy, S.A., Neaton, J.D., Rotnitzky, A., Scharfstein, D., Shih, W.J., Siegel, J.P., Stern, H.: The prevention and treatment of missing data in clinical trials. N. Engl. J. Med. 367(14), 1355–1360 (2012). https://doi.org/10.1056/NEJMsr1203730
WHO: Framework Convention on Tobacco Control. Word Health Organization, Geneva (2003)
Irvin, J.E., Brandon, T.H.: The increasing recalcitrance of smokers in clinical trials. Nicotine Tob. Res. 2(1), 79–84 (2000). https://doi.org/10.1080/14622200050011330
Funding
This study was funded by the National Heart, Lung, and Blood Institute (5R01-HL094183-05, Thomas, PI). The parent trial is registered with Clinical Trials.Gov, NCT01096108.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
None to declare.
Ethics approval
The trial was approved by the University of Minnesota Human Subjects Committee. See primary publication [10] for details.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Popp, J., Nyman, J.A., Luo, X. et al. Cost-effectiveness of enhancing a Quit-and-Win smoking cessation program for college students. Eur J Health Econ 19, 1319–1333 (2018). https://doi.org/10.1007/s10198-018-0977-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10198-018-0977-z
Keywords
- Economic evaluation
- Cost utility
- Smoking cessation
- Financial incentives
- College smoking
- Decision-analytic model